Tropical diseases

Worldwide Malaria Treatment Industry to 2027 - Increasing Research for New Drugs and Vaccines Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Monday, March 15, 2021

The report highlights the key factors driving the market growth and prominent players with their developments in the market.

Key Points: 
  • The report highlights the key factors driving the market growth and prominent players with their developments in the market.
  • Based on treatment type, the malaria treatment market is segmented into vaccine, diagnostic test, and antimalarial agents.
  • The growth of the malaria treatment market is attributed to the high prevalence of malaria in low-income countries, and increasing initiatives undertaken by governments globally.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the malaria treatment market.

NLR: Millions at risk of developing leprosy: new study predicts 40 million people need preventive treatment to eliminate leprosy in 22 years

Retrieved on: 
Monday, March 1, 2021

Co-author Professor Jan Hendrik Richardus of Erasmus MC explains: "This study provides important insight into the challenge that remains to reach zero leprosy.

Key Points: 
  • Co-author Professor Jan Hendrik Richardus of Erasmus MC explains: "This study provides important insight into the challenge that remains to reach zero leprosy.
  • This study shows that to reduce the global number of new leprosy cases by 90% within 22 years, just over 40 million people who are at risk to develop leprosy require preventive treatment.
  • On a global scale, preventive treatment of 40 million people for leprosy is achievable if we coordinate our resources and efforts.
  • This should be done by targeting people most at risk of developing leprosy: close contacts (family, friends, neighbors) of new leprosy patients.

NLR: Millions at risk of developing leprosy: new study predicts 40 million people need preventive treatment to eliminate leprosy in 22 years

Retrieved on: 
Monday, March 1, 2021

Co-author Professor Jan Hendrik Richardus of Erasmus MC explains: "This study provides important insight into the challenge that remains to reach zero leprosy.

Key Points: 
  • Co-author Professor Jan Hendrik Richardus of Erasmus MC explains: "This study provides important insight into the challenge that remains to reach zero leprosy.
  • This study shows that to reduce the global number of new leprosy cases by 90% within 22 years, just over 40 million people who are at risk to develop leprosy require preventive treatment.
  • On a global scale, preventive treatment of 40 million people for leprosy is achievable if we coordinate our resources and efforts.
  • This should be done by targeting people most at risk of developing leprosy: close contacts (family, friends, neighbors) of new leprosy patients.

Global Disease Expert Available to Comment on New Ebola Outbreak in Guinea

Retrieved on: 
Wednesday, February 17, 2021

RESEARCH TRIANGLE PARK, N.C., Feb. 17, 2021 /PRNewswire/ -- Richard Reithinger , Ph.D., Vice President of Global Health at RTI International (RTI), a nonprofit research institute, is available to comment on the new Ebola outbreak in Guinea, which has been proclaimed an epidemic.

Key Points: 
  • RESEARCH TRIANGLE PARK, N.C., Feb. 17, 2021 /PRNewswire/ -- Richard Reithinger , Ph.D., Vice President of Global Health at RTI International (RTI), a nonprofit research institute, is available to comment on the new Ebola outbreak in Guinea, which has been proclaimed an epidemic.
  • Dr. Reithinger is an infectious disease expert with extensive experience managing health programs around the globe.
  • Infectious disease SME Dr. Richard Reithinger can comment on new Ebola outbreak in Guinea, now considered an epidemic.
  • During the Ebola outbreak in Guinea from 2014-2016, RTI aided the Guinean government and supported USAID's StopPalu project to mitigate the impact of Ebola on malaria treatment programs.

Antler Gold Appoints Christopher Drysdale as Vice President and Provides Exploration Update on Its Erongo Gold Project, Central Namibia

Retrieved on: 
Tuesday, February 16, 2021

Christopher was previously Antler's Manager of Corporate Development and was directly responsible for Antler having the opportunity to secure the Erongo Project.

Key Points: 
  • Christopher was previously Antler's Manager of Corporate Development and was directly responsible for Antler having the opportunity to secure the Erongo Project.
  • Antler also provides an update on exploration currently underway on the project.
  • Antler Gold Inc. (TSXV: ANTL) is a Canadian company, focused on the acquisition and exploration of gold projects in Namibia.
  • For further information, please contact Daniel Whittaker, President and CEO of Antler Gold Inc., at (902) 488-4700.

Ebola virus disease in Nzérékoré – Guinea

Retrieved on: 
Tuesday, February 16, 2021

On 14 February 2021, an Ebola virus disease (EVD) outbreak was declared in the rural area of Gouk in NZerekore region, Guinea, by national health authorities.

Key Points: 
  • On 14 February 2021, an Ebola virus disease (EVD) outbreak was declared in the rural area of Gouk in NZerekore region, Guinea, by national health authorities.
  • Samples from the confirmed cases have been sent to the Institut Pasteur in Senegal for full genome sequencing in order to identify the strain of the Ebola virus.
  • Significant developments have been made in the prevention of Ebola virus disease, with two vaccines now licensed for use in several countries.
  • For other EU/EEA citizens living in or travelling through Guinea, the likelihood of exposure is very low, as is the likelihood of introduction and further spread of the Ebola virus within the EU/EEA.

Outbreak of Ebola virus disease in North Kivu – Democratic Republic of the Congo – 2021

Retrieved on: 
Tuesday, February 16, 2021

On 7 February 2021, the Minister of Health of the Democratic Republic of the Congo (DRC) declared an outbreak of Ebola virus disease after a laboratory-confirmed case was detected.

Key Points: 
  • On 7 February 2021, the Minister of Health of the Democratic Republic of the Congo (DRC) declared an outbreak of Ebola virus disease after a laboratory-confirmed case was detected.
  • This current outbreak constitutes the 12th outbreak of Ebola virus disease in the DRC.
  • Her husband was an Ebola virus disease survivor whose biological samples had tested negative twice since 28 September 2020; she died on 4 February 2021.
  • In addition, as the virus is present in the animal reservoir in many parts of the country, Ebola virus disease outbreaks are recurrent.

PaxMedica Receives FDA Orphan Drug Designation for Use of PAX-101 (IV suramin) in a Rare Tropical Disease

Retrieved on: 
Tuesday, February 2, 2021

Receiving this designation from the FDA is an important milestone for PaxMedica and the treatment of HAT, said Howard Weisman, CEO of PaxMedica.

Key Points: 
  • Receiving this designation from the FDA is an important milestone for PaxMedica and the treatment of HAT, said Howard Weisman, CEO of PaxMedica.
  • As there are no FDA approved treatments for HAT, access to effective medicines has been difficult and inconsistent for US citizens and residents.
  • Human African Trypanosomiasis (HAT) is a neglected tropical disease commonly known as African sleeping sickness.
  • PaxMedica has exclusively licensed patient data from East African Ministries of Health and hospitals where patients with the disease are treated.

January 30th to Mark the Second Annual World NTD Day

Retrieved on: 
Friday, January 29, 2021

The UAE has spearheaded diplomatic efforts to obtain official recognition of the day by The World Health Organization and has played a lead role in galvanizing partners and supporting the day.

Key Points: 
  • The UAE has spearheaded diplomatic efforts to obtain official recognition of the day by The World Health Organization and has played a lead role in galvanizing partners and supporting the day.
  • The World Health Organizations new NTD Roadmap is a rallying cry that tells us that not only is beating NTDs possible, its possible within a decade.
  • This years World NTD Day is drawing attention to the launch of the World Health Organizations new roadmap to end NTDs.
  • Recognizing that the annual celebration of the day provides a vital service to the worlds work to end NTDs, the World Health Organizations Executive Board passed a decision on 23 January recommending that WHO officially support activities marking 30 January as World NTD Day, and inviting Member States and others to celebrate the day.

Orbis International Celebrates 22 Years of Achievements in Trachoma Elimination in Ethiopia this World Neglected Tropical Diseases Day

Retrieved on: 
Thursday, January 28, 2021

NEW YORK, Jan. 28, 2021 /PRNewswire/ --Ahead of World Neglected Tropical Diseases Day, leading eye care nonprofit Orbis proudly celebrates 22 years of working to eliminate the blindness-causing infection trachoma in Ethiopia.

Key Points: 
  • NEW YORK, Jan. 28, 2021 /PRNewswire/ --Ahead of World Neglected Tropical Diseases Day, leading eye care nonprofit Orbis proudly celebrates 22 years of working to eliminate the blindness-causing infection trachoma in Ethiopia.
  • All procedures were conducted with COVID-19 prevention protocols, including the use of personal protective equipment (PPE), in place.
  • Normally, MDAs take place in community settings in Ethiopia, but preventing the spread of COVID-19 required that the Orbis team take a door-to-door approach.
  • Orbis also leads trachoma-related research, including conducting more than 100 trachoma impact and surveillance surveys across Ethiopia's SNNPR between 2013 and 2019.